• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

传播率:临床乳腺炎成本的一个主要决定因素。

Rate of transmission: a major determinant of the cost of clinical mastitis.

作者信息

Down P M, Green M J, Hudson C D

机构信息

School of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington Campus, Sutton Bonington, LE12 5RD, United Kingdom.

出版信息

J Dairy Sci. 2013 Oct;96(10):6301-14. doi: 10.3168/jds.2012-6470. Epub 2013 Aug 16.

DOI:10.3168/jds.2012-6470
PMID:23958003
Abstract

The aim of this research was to use probabilistic sensitivity analysis to evaluate the relative importance of different components of a model designed to estimate the cost of clinical mastitis (CM). A particular focus was placed on the importance of pathogen transmission relative to other factors, such as milk price or treatment costs. A stochastic Monte Carlo model was developed to simulate a case of CM at the cow level and to calculate the associated costs for 5 defined treatment protocols. The 5 treatment protocols modeled were 3 d of antibiotic intramammary treatment, 5 d of antibiotic intramammary treatment, 3 d of intramammary and systemic antibiotic treatment, 3d of intramammary and systemic antibiotic treatment plus 1 d of nonsteroidal antiinflammatory drug treatment, and 5 d of intramammary and systemic antibiotic treatment. Uniform distributions were used throughout the model to enable investigation of the cost of CM over a spectrum of clinically realistic scenarios without specifying which scenario was more or less likely. A risk of transmission parameter distribution, based on literature values, was included to model the effect of pathogen transmission to uninfected cows, from cows that remained subclinically infected after treatment for CM. Spearman rank correlation coefficients were used to evaluate the relationships between model input values and the estimated cost of CM. Linear regression models were used to explore the effect that changes to specific independent variables had on the cost of CM. Risk of transmission was found to have the strongest association with the cost of CM, followed by bacteriological cure rate, cost of culling, and yield loss. Other factors such as milk price, cost of labor, and cost of medicines were of minimal influence in comparison. The cost of CM was similar for all 5 treatment protocols. The results from this study suggest that, when seeking to minimize the economic impact of CM in dairy herds, great emphasis should be placed on the reduction of pathogen transmission from cows with CM to uninfected cows.

摘要

本研究的目的是使用概率敏感性分析来评估一个旨在估算临床型乳腺炎(CM)成本的模型中不同组成部分的相对重要性。特别关注病原体传播相对于其他因素(如牛奶价格或治疗成本)的重要性。开发了一个随机蒙特卡洛模型,以模拟奶牛层面的一例CM病例,并计算5种既定治疗方案的相关成本。所模拟的5种治疗方案分别是:3天的抗生素乳房内治疗、5天的抗生素乳房内治疗、3天的乳房内和全身性抗生素治疗、3天的乳房内和全身性抗生素治疗加1天的非甾体抗炎药治疗,以及5天的乳房内和全身性抗生素治疗。在整个模型中使用均匀分布,以便在一系列临床现实场景中研究CM的成本,而无需指定哪种场景更有可能或更不可能。基于文献值纳入了传播参数分布风险,以模拟病原体从治疗CM后仍处于亚临床感染状态的奶牛传播到未感染奶牛的影响。使用斯皮尔曼等级相关系数来评估模型输入值与CM估计成本之间的关系。使用线性回归模型来探讨特定自变量的变化对CM成本的影响。发现传播风险与CM成本的关联最强,其次是细菌学治愈率、淘汰成本和产量损失。相比之下,其他因素如牛奶价格、劳动力成本和药品成本的影响最小。所有5种治疗方案的CM成本相似。本研究结果表明,当试图将CM对奶牛群的经济影响降至最低时,应高度重视减少从患有CM的奶牛向未感染奶牛的病原体传播。

相似文献

1
Rate of transmission: a major determinant of the cost of clinical mastitis.传播率:临床乳腺炎成本的一个主要决定因素。
J Dairy Sci. 2013 Oct;96(10):6301-14. doi: 10.3168/jds.2012-6470. Epub 2013 Aug 16.
2
Cow-specific treatment of clinical mastitis: an economic approach.牛特有的临床乳腺炎治疗方法:一种经济方法。
J Dairy Sci. 2011 Jan;94(1):174-88. doi: 10.3168/jds.2010-3367.
3
Factors affecting the cost-effectiveness of on-farm culture prior to the treatment of clinical mastitis in dairy cows.影响奶牛临床型乳腺炎治疗前农场养殖成本效益的因素。
Prev Vet Med. 2017 Sep 15;145:91-99. doi: 10.1016/j.prevetmed.2017.07.006. Epub 2017 Jul 10.
4
Addition of meloxicam to the treatment of bovine clinical mastitis results in a net economic benefit to the dairy farmer.向奶牛临床乳腺炎的治疗中添加美洛昔康可使奶农获得净经济效益。
J Dairy Sci. 2018 Apr;101(4):3387-3397. doi: 10.3168/jds.2017-12869. Epub 2018 Feb 2.
5
Bioeconomic modeling of intervention against clinical mastitis caused by contagious pathogens.传染性病原体引起的临床乳腺炎干预的生物经济模型。
J Dairy Sci. 2012 Oct;95(10):5740-9. doi: 10.3168/jds.2012-5470. Epub 2012 Aug 3.
6
Use of partial budgeting to determine the economic benefits of antibiotic treatment of chronic subclinical mastitis caused by Streptococcus uberis or Streptococcus dysgalactiae.运用局部预算法来确定由乳房链球菌或停乳链球菌引起的慢性亚临床乳腺炎进行抗生素治疗的经济效益。
J Dairy Res. 2005 Feb;72(1):75-85. doi: 10.1017/s0022029904000603.
7
The cost of generic clinical mastitis in dairy cows as estimated by using dynamic programming.采用动态规划法估算的奶牛普通临床型乳腺炎的成本。
J Dairy Sci. 2008 Jun;91(6):2205-14. doi: 10.3168/jds.2007-0573.
8
Optimal insemination and replacement decisions to minimize the cost of pathogen-specific clinical mastitis in dairy cows.优化授精和替换决策以最小化奶牛特定病原体临床型乳房炎的成本。
J Dairy Sci. 2014;97(4):2101-17. doi: 10.3168/jds.2013-7067. Epub 2014 Feb 15.
9
Effect of treatment with the nonsteroidal antiinflammatory meloxicam on milk production, somatic cell count, probability of re-treatment, and culling of dairy cows with mild clinical mastitis.非甾体抗炎药美洛昔康治疗对患有轻度临床型乳腺炎的奶牛产奶量、体细胞计数、再次治疗概率及淘汰率的影响。
J Dairy Sci. 2009 Sep;92(9):4421-31. doi: 10.3168/jds.2009-2284.
10
Randomized noninferiority trial comparing 2 commercial intramammary antibiotics for the treatment of nonsevere clinical mastitis in dairy cows.比较两种市售乳房内用抗生素治疗奶牛非严重临床型乳腺炎的随机非劣效性试验。
J Dairy Sci. 2016 Oct;99(10):8267-8281. doi: 10.3168/jds.2016-11258. Epub 2016 Aug 10.

引用本文的文献

1
The Economic Evaluation of Mastitis Control Strategies in Holstein-Friesian Dairy Herds.荷斯坦-弗里生奶牛群乳腺炎控制策略的经济评估
Animals (Basel). 2023 May 20;13(10):1701. doi: 10.3390/ani13101701.
2
A PK/PD model for the evaluation of clinical rifaximin dosage for the treatment of dairy cow mastitis induced by Escherichia coli.用于评估利福昔明治疗大肠杆菌引起的奶牛乳腺炎的临床剂量的 PK/PD 模型。
BMC Vet Res. 2023 Jan 21;19(1):19. doi: 10.1186/s12917-022-03564-2.
3
Virulence and antimicrobial resistance gene profiles of Staphylococcus aureus associated with clinical mastitis in cattle.
牛源临床型乳腺炎金黄色葡萄球菌的毒力和抗菌药物耐药基因特征。
PLoS One. 2022 May 3;17(5):e0264762. doi: 10.1371/journal.pone.0264762. eCollection 2022.
4
An Observational Study Investigating Potential Risk Factors and Economic Impact for Bovine Ischaemic Teat Necrosis on Dairy Farms in Great Britain.一项关于英国奶牛场牛缺血性乳头坏死潜在风险因素及经济影响的观察性研究。
Front Vet Sci. 2022 Mar 22;9:748259. doi: 10.3389/fvets.2022.748259. eCollection 2022.
5
Engaging with selective dry cow therapy: understanding the barriers and facilitators perceived by Irish farmers.采用选择性干奶牛疗法:了解爱尔兰奶农所感知到的障碍和促进因素。
Ir Vet J. 2021 Oct 23;74(1):28. doi: 10.1186/s13620-021-00207-0.
6
PCR-Based Direct Detection of from Subclinical and Clinical Dairy Cattle Milk Samples.基于聚合酶链反应的亚临床和临床奶牛乳样中[具体物质未给出]的直接检测
Vet Med Int. 2020 Dec 8;2020:8828624. doi: 10.1155/2020/8828624. eCollection 2020.
7
Financial and economic analyses of the impact of cattle mastitis on the profitability of Egyptian dairy farms.奶牛乳腺炎对埃及奶牛场盈利能力影响的财务与经济分析。
Vet World. 2020 Sep;13(9):1750-1759. doi: 10.14202/vetworld.2020.1750-1759. Epub 2020 Sep 2.
8
Acute phase protein expressions in secretory and cistern lining epithelium tissues of the dairy cattle mammary gland during chronic mastitis caused by staphylococci.奶牛慢性乳房炎金黄色葡萄球菌感染时乳导管和腺泡衬里上皮组织中急性期蛋白的表达
BMC Vet Res. 2020 Aug 31;16(1):320. doi: 10.1186/s12917-020-02544-8.
9
Genomic analysis and immune response in a murine mastitis model of vB_EcoM-UFV13, a potential biocontrol agent for use in dairy cows.vB_EcoM-UFV13 诱导的小鼠乳腺炎模型中的基因组分析和免疫反应,该菌有望成为奶牛用生物防治剂。
Sci Rep. 2018 May 1;8(1):6845. doi: 10.1038/s41598-018-24896-w.
10
Chitosan and cloxacillin combination improve antibiotic efficacy against different lifestyle of coagulase-negative Staphylococcus isolates from chronic bovine mastitis.壳聚糖和氯唑西林联合应用可提高抗生素对慢性牛乳腺炎凝固酶阴性葡萄球菌不同生活方式分离株的疗效。
Sci Rep. 2018 Mar 23;8(1):5081. doi: 10.1038/s41598-018-23521-0.